Industry Perspectives | Products | Product News

EpiCypher has launched meCUT&RUN and Multiomic CUT&RUN, two cost-effective tools for high-resolution DNA methylation and multiomic epigenomic profiling.

Bruker has launched Beacon Discovery™, a benchtop system for live single-cell analysis designed for broader use in academic and translational research.

Built on the legacy of three trusted brands – BioTrading, Redipor by Cherwell, and NEL – Redipor by AnalytiChem brings together over 150 years of prepared media expertise, innovation and heritage into one unique global brand.

Promising new data shows that Factor H (CPV-104) significantly reduces inflammation and retinal degeneration in an animal model of dry age-related macular degeneration

Cyprumed GmbH and MSD have entered a non-exclusive agreement to develop oral peptide formulations using Cyprumed’s delivery technology.

ProBioGen announced the commercial launch of Ziihera®, a bispecific antibody for HER2-positive biliary tract cancer developed with its GlymaxX® technology.

A new benchtop system enables real-time live single-cell functional analysis for immune response, antibody discovery, and cell therapy.

Synthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods.

Innovations like ClinFAST™ are streamlining the fill/finish process, reducing timelines while maintaining high-quality standards for clinical materials.

A groundbreaking approach targets muscle stem cells to restore regeneration in Duchenne muscular dystrophy, offering new hope beyond traditional dystrophin-focused therapies.

Advances in flow cytometry are accelerating drug discovery by enabling high-throughput, automated single-cell analysis.

Researchers gain a deeper understanding of disease mechanisms through integrating 3D multiomics, paving the way for more precise and efficient drug discovery.

New technologies aim to enhance single-cell analysis and empower researchers with unprecedented insight into cellular function and tissue architecture.

New modality drugs offer promising therapeutic approaches to address unmet medical needs – but not without challenges.

An innovative mass spectrometry system breaks barriers in protein analysis with exceptional sensitivity, speed, and accuracy. 

Labs are embracing electronic lab notebooks to streamline workflows and boost efficiency.

A next-generation 3D cell culture platform enhances scalability, reproducibility, and efficiency, empowering researchers to create biologically relevant models.  

Automated bioanalytics drives research forward with greater precision and efficiency.

AI helps researchers reveal unexpected connections between human diseases and biological pathways, bringing new therapeutic insights.

Takara Bio USA enhances single-cell omics with Curio Bioscience acquisition, expanding spatial biology solutions.